Deferred Tax Assets, Valuation Allowance in USD of Burning Rock Biotech Ltd from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2024.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $81.6M, a 8.26% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $81.6M +$6.23M +8.26% Dec 31, 2024 20-F 2025-04-29
Q4 2023 $75.4M +$12.1M +19.1% Dec 31, 2023 20-F 2024-04-29
Q4 2022 $63.3M +$21.9M +52.8% Dec 31, 2022 20-F 2023-04-20
Q4 2021 $41.5M +$15.4M +58.8% Dec 31, 2021 20-F 2022-04-29
Q4 2020 $26.1M Dec 31, 2020 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.